1. Volume 53, Issue 6, Pages 1172-1179 (June 2008)
Long-Term Outcome Following Three-Dimensional Conformal/Intensity-Modulated External-Beam Radiotherapy for Clinical Stage T3 Prostate Cancer 
Michael J. Zelefsky, Yoshiya Yamada, Marisa A. Kollmeier, Alison M. Shippy, Michelle A. Nedelka 
European Urology 
Volume 53, Issue 6, Pages (June 2008)
DOI: /j.eururo
Copyright © 2007 European Association of Urology Terms and Conditions

2. Fig. 1
Biochemical progression-free survival for patients treated with neoadjuvant and concurrent androgen-deprivation therapy who received higher (≥75Gy) doses versus lower doses.
European Urology  , DOI: ( /j.eururo )
Copyright © 2007 European Association of Urology Terms and Conditions

3. Fig. 2
Local progression-free survival rate for patients treated with and without androgen-deprivation therapy.
European Urology  , DOI: ( /j.eururo )
Copyright © 2007 European Association of Urology Terms and Conditions

4. Fig. 3
Distant metastases-free survival outcomes for patients treated to ≥8100cGy in conjunction with neoadjuvant and concurrent androgen-deprivation therapy, T3a versus T3b patients.
European Urology  , DOI: ( /j.eururo )
Copyright © 2007 European Association of Urology Terms and Conditions

5. Fig. 4
Cause-specific survival outcomes for patients treated to ≥8100cGy in conjunction with neoadjuvant and concurrent androgen-deprivation therapy, T3a versus T3b patients.
European Urology  , DOI: ( /j.eururo )
Copyright © 2007 European Association of Urology Terms and Conditions